Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ablynx Nv (ABLYF)

Ablynx Nv (ABLYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 3,809,908
  • Shares Outstanding, K 75,250
  • Annual Sales, $ 62,770 K
  • Annual Income, $ -122,670 K
  • 60-Month Beta 8.25
  • Price/Sales 63.94
  • Price/Cash Flow N/A
  • Price/Book 18.69
Trade ABLYF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 04/04/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.6300 unch
on 05/24/18
54.0500 -6.33%
on 04/26/18
-4.4100 (-8.01%)
since 04/18/18
3-Month
50.6300 unch
on 05/24/18
55.0400 -8.01%
on 04/18/18
-3.3244 (-6.16%)
since 02/23/18
52-Week
12.5000 +305.04%
on 05/31/17
55.0400 -8.01%
on 04/18/18
+38.1500 (+305.69%)
since 05/16/17

Business Summary

Ablynx NV is a biopharmaceutical company which engaged in the development of Nanobodies (R) proprietary therapeutic proteins based on single-domain antibody fragments. The company also discovers and develops therapeutic for inflammation, haematology, immuno-oncology, oncology and respiratory disease....

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 50.6300
1st Resistance Point 50.6300
Last Price 50.6300
1st Support Level 50.6300
2nd Support Level 50.6300
3rd Support Level N/A

See More

52-Week High 55.0400
Last Price 50.6300
Fibonacci 61.8% 38.7897
Fibonacci 50% 33.7700
Fibonacci 38.2% 28.7503
52-Week Low 12.5000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar